# reload+after+2024-01-20 15:43:19.081151
address1§3480 Peachtree Road NE
address2§Second Floor, Suite 103
city§Atlanta
state§GA
zip§30326
country§United States
phone§844 722 6333
website§https://www.alzamend.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
fullTimeEmployees§4
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Stephan  Jackman', 'age': 46, 'title': 'CEO & Director', 'yearBorn': 1977, 'fiscalYear': 2023, 'totalPay': 434236, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David J. Katzoff', 'age': 61, 'title': 'Chief Financial Officer', 'yearBorn': 1962, 'fiscalYear': 2023, 'totalPay': 116667, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Henry C. W. Nisser Esq.', 'age': 54, 'title': 'Executive VP, General Counsel & Director', 'yearBorn': 1969, 'fiscalYear': 2023, 'totalPay': 50000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kenneth S. Cragun CPA', 'age': 62, 'title': 'Senior Vice President of Finance', 'yearBorn': 1961, 'fiscalYear': 2023, 'exercisedValue': 0, 'unexercisedValue': 25000}]
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.145
currency§USD
dateShortInterest§1702598400
forwardEps§-2.33
exchange§NCM
quoteType§EQUITY
shortName§Alzamend Neuro, Inc.
longName§Alzamend Neuro, Inc.
firstTradeDateEpochUtc§1623763800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b0577044-824a-3769-9c91-1a7bb4b1f2b7
gmtOffSetMilliseconds§-18000000
targetHighPrice§25.0
targetLowPrice§15.0
targetMeanPrice§20.0
targetMedianPrice§20.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§0.055
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
